Inactive Instrument
Immune Pharmaceuticals, Inc. Stock
Stocks
FZRQ
US45254C2008
Pharmaceuticals
OTC Markets Traded| 1 day | +300.00% |
| Manager | Title | Age | Since |
|---|---|---|---|
Devin J. Shaw
DFI | Director of Finance/CFO | 39 | 2021-04-12 |
John Zhang
CTO | Chief Tech/Sci/R&D Officer | - | 2017-12-10 |
Boris Shor
PRN | Corporate Officer/Principal | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
David Sidransky
BRD | Director/Board Member | 66 | 2013-08-25 |
Daniel Kazado
CHM | Chairman | 61 | 2013-10-09 |
John A. Neczesny
BRD | Director/Board Member | 62 | 2016-02-01 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 2/3/20 | Sell | Director | 75,000 | 0.0412% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +300.00% | -.--% | - | - | 386K | |
| +1.38% | -3.37% | +48.88% | +162.98% | 1,031B | |
| +1.11% | -3.53% | +51.69% | +57.13% | 595B | |
| +3.39% | +0.99% | +32.43% | +87.19% | 431B | |
| +0.42% | -1.16% | +29.43% | +23.64% | 326B | |
| +1.03% | -0.84% | +29.58% | +45.15% | 277B | |
| +0.49% | -5.44% | +21.00% | +23.80% | 263B | |
| +1.59% | +4.89% | -22.56% | -37.35% | 224B | |
| +3.15% | +1.60% | +23.55% | +62.15% | 193B | |
| +2.71% | +0.22% | +23.02% | +74.41% | 164B | |
| Average | +31.46% | -3.79% | +26.34% | +55.46% | 389.37B | |
| Weighted average by Cap. | +1.50% | -4.31% | +34.74% | +80.46% |
Employees
7
Sector
Pharmaceuticals
Choose MarketScreener 
